Skip to search formSkip to main contentSkip to account menu

brequinar sodium

Known as: Sodium 6-Fluoro-2-(2'-fluoro-4-biphenylyl)-3-methyl-4-quinolinecarboxylate 
The sodium salt form of Brequinar. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby blocking de novo pyrimidine biosynthesis. This… 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

DuP 785
NCIt Antineoplastic Agent Terminologybrequinar

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Structural and functional comparison of agents interfering with dihydroorotate, succinate and NADH oxidation of rat liver mitochondria.
Highly Cited
1996
Highly Cited
1996
The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase.
The active metabolite of leflunomide. A771726, is a novel immunosuppressive compound that has been shown to be a powerful… 
1994
1994
EVALUATION OF CYCLOSPORINE, MYCOPHENOLATE MOFETIL, AND BREQUINAR SODIUM COMBINATION THERAPY ON HAMSTER‐TO-RAT CARDIAC XENOTRANSPLANTATION
We examined the effect of CsA, mycophenolate mofetil (MM), and Brequinar sodium (BQR) combination therapy on hamster-to-rat… 
Review
1993
Review
1993
The Development of Brequinar as an Immunosuppressive Drug for Transplantation
The preclinical and clinical characterization of Brequinar sodium has demonstrated the potential for the use of this drug as a… 
1993
1993
The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination.
The rigorous median-effect analysis was used to assess the interactions between cyclosporine and drugs that inhibit nucleotide… 
Highly Cited
1992
Highly Cited
1992
Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium.
The novel anticancer drug candidate brequinar sodium (DuP 785, NSC 368390, 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4… 
Highly Cited
1992
Highly Cited
1992
THE EFFECT OF A NEW IMMUNOSUPPRESSIVE DRUG, BREQUINAR SODIUM, ON HEART, LIVER, AND KIDNEY ALLOGRAFT REJECTION IN THE RAT
Brequinar sodium (BQR) prevents cell proliferation by virtue of its inhibition of de novo pyrimidine biosynthesis. BQR is capable… 
Highly Cited
1990
Highly Cited
1990
In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.
Little is known about the in vivo effects of inhibition of the mitochondrial pyrimidine de novo synthesis enzyme dihydroorotic… 
Highly Cited
1990
Highly Cited
1990
Structure-activity relationship of quinoline carboxylic acids. A new class of inhibitors of dihydroorotate dehydrogenase.
Highly Cited
1989
Highly Cited
1989
Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).
Brequinar sodium is a 4-quinolinecarboxylic acid analogue that inhibits dihydroorotate dehydrogenase and subsequent de novo… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)